IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.216
NA - Nord America 7.370
AS - Asia 4.244
SA - Sud America 1.488
AF - Africa 129
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 2
Totale 22.463
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.219
RU - Federazione Russa 4.663
SG - Singapore 1.772
CN - Cina 1.326
BR - Brasile 1.272
IE - Irlanda 1.029
SE - Svezia 1.027
IT - Italia 653
HK - Hong Kong 438
DE - Germania 426
UA - Ucraina 316
FR - Francia 301
VN - Vietnam 233
PL - Polonia 215
FI - Finlandia 206
GB - Regno Unito 190
IN - India 113
AR - Argentina 79
CA - Canada 69
BD - Bangladesh 56
MX - Messico 50
BE - Belgio 42
ZA - Sudafrica 39
JP - Giappone 38
TR - Turchia 35
EC - Ecuador 33
NL - Olanda 33
IQ - Iraq 30
UZ - Uzbekistan 26
MA - Marocco 23
AT - Austria 22
CO - Colombia 22
ID - Indonesia 22
PK - Pakistan 22
ES - Italia 20
VE - Venezuela 18
IR - Iran 17
CZ - Repubblica Ceca 15
UY - Uruguay 15
EG - Egitto 14
TN - Tunisia 14
PH - Filippine 13
PY - Paraguay 13
AL - Albania 12
PE - Perù 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
CL - Cile 11
KE - Kenya 10
AZ - Azerbaigian 9
JM - Giamaica 9
SA - Arabia Saudita 9
BO - Bolivia 8
KZ - Kazakistan 8
RO - Romania 8
JO - Giordania 7
KR - Corea 7
LT - Lituania 7
MY - Malesia 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
OM - Oman 6
GY - Guiana 5
KH - Cambogia 5
RS - Serbia 5
AM - Armenia 4
DZ - Algeria 4
LB - Libano 4
LU - Lussemburgo 4
MN - Mongolia 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
GE - Georgia 2
GT - Guatemala 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BW - Botswana 1
CG - Congo 1
Totale 22.445
Salva come PNG Salva come JPEG
Città #
Ashburn 1.330
Moscow 1.305
Dublin 1.029
Singapore 1.027
Chandler 736
Dallas 682
Jacksonville 648
Nyköping 513
Beijing 482
Hong Kong 437
San Jose 320
Warsaw 201
The Dalles 189
Messina 187
Princeton 170
Boardman 162
Los Angeles 161
Lauterbourg 160
Cambridge 157
Medford 153
Dearborn 144
Ann Arbor 139
Des Moines 128
São Paulo 103
Munich 101
Buffalo 80
Ho Chi Minh City 80
New York 74
Council Bluffs 58
Jinan 58
Woodbridge 53
Hanoi 52
Santa Clara 49
Frankfurt am Main 46
Wilmington 44
Redondo Beach 42
Guangzhou 41
Tianjin 41
Shenyang 40
Brussels 39
Belo Horizonte 37
Catania 35
Turku 35
San Mateo 33
Orem 31
Rio de Janeiro 31
Bremen 30
Tokyo 30
Zhengzhou 30
Hyderabad 29
Brooklyn 28
Lancaster 28
Düsseldorf 26
Hebei 26
Houston 26
London 26
Curitiba 25
Porto Alegre 24
Shanghai 24
Brasília 23
Chennai 23
Helsinki 23
Seattle 23
Milan 22
Montreal 22
Rome 22
Tashkent 22
Denver 21
Ningbo 21
Johannesburg 20
Shenzhen 20
Nanjing 19
Stockholm 19
Boston 18
Haikou 17
Pune 17
Taizhou 17
Chicago 16
Atlanta 15
San Francisco 15
Sorocaba 15
Baghdad 14
Dong Ket 14
Manchester 14
Ottawa 14
Washington 14
Fortaleza 13
Mexico City 13
Campinas 12
Guarulhos 12
Guayaquil 12
Montevideo 12
Quito 12
Amsterdam 11
Campo Grande 11
Goiânia 11
Hefei 11
Jakarta 11
Lanzhou 11
Mumbai 11
Totale 12.678
Salva come PNG Salva come JPEG
Nome #
Inositolo e sindrome metabolica in menopausa 291
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 244
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 233
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 232
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 228
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 227
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 218
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 218
Italian risk factor-based screening for gestational diabetes. 208
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 207
Myo-inositol and melatonin in the menopausal transition 206
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 205
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 204
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 202
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 199
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 196
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 193
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 193
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 191
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 190
Myo-inositol may prevent gestational diabetes in PCOS women 189
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 188
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 188
Effects of myo-inositol on glucose variability in women with gestational diabetes 183
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 182
Cardiovascular effects of raloxifene hydrochloride 182
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 181
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 179
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 178
C-reactive protein as an early predictor of gestational diabetes mellitus 175
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 175
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 175
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 172
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 170
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 170
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 169
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 168
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 168
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 168
Cardiovascular effects of the phytoestrogen genistein 167
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 167
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 167
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 166
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 166
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 165
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 164
Dietary management of skin health: The role of genistein 164
ADAM 12 come marker precoce di preeclampsia 163
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 163
Compliance with hormone replacement therapy in postmenopausal Sicilian women 162
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 162
Maternal serum PAPP-A as an early marker of obstetric complications? 160
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 159
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 157
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 157
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 156
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 154
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 154
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 153
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 152
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 150
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 150
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 150
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 149
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 149
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 147
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 147
Midtrimester amniotic fluid adiponectin in normal pregnancy. 147
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 144
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 144
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 142
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 142
Pregnancy outcome following mid-trimester amniocentesis 141
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 140
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 139
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 139
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 139
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 139
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 137
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 136
La disfunzione diastolica nel diabete gestazionale 136
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 136
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 133
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 133
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 132
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 129
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 128
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 128
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 127
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 126
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 124
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women 120
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 119
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 118
Livelli serici di OPG e RANKL in donne osteopeniche in post-menopausa, trattate per 2 anni col fitoestrogeno genisteina 116
Use of diet and myoinositol in postmenopausal women: a new approach to the metabolic syndrome 115
Valutazione ecocardiografica in pazienti affette da diabete mellito gestazionale: Dati preliminari 113
GENISTEIN AGLYCONE: A DUAL MODE OF ACTION ANTI-OSTEOPOROTIC SOY ISOFLAVONE REBALANCING BONE TURNOVER TOWARDS BONE FORMATION 113
The impact of kidney development on the life course: a consensus document for action 113
The clinical utility of serum uric acid measurements in pre- eclampsia and transient hypertension in pregnancy 112
Totale 16.365
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.445
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 0 0 0 0 0 0 54
2021/20221.216 11 145 29 44 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/20253.387 68 29 70 221 147 132 54 717 850 238 325 536
2025/202610.745 595 724 733 759 811 2.217 1.282 1.359 1.458 422 186 199
Totale 22.732